Hypnotic drug use in Spain: A cross-sectional study based on a network of community pharmacies

Annals of Pharmacotherapy

Volumn 30, Issue 10, 1996, Pages 1092-1100

  Rayón, Pilar ^a   Serrano Castro, Mariantonia ^a,b   Del Barrio, Horacio ^c   Alvarez, Carmen ^b   Montero, Dolores ^a   Madurga, Mariano ^a   Palop, Ramón ^a   De Abajo, Francisco J ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b MINISTERIO DE SANIDAD Y CONSUMO   (Spain)

^c Red Espanola de Atencion Primaria   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BROTIZOLAM; CLOMETHIAZOLE; FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC AGENT; LOPRAZOLAM; LORAZEPAM; LORMETAZEPAM; MIDAZOLAM; NITRAZEPAM; QUAZEPAM; TRIAZOLAM; ZOLPIDEM; ZOPICLONE;

ADULT; AGED; ARTICLE; DOSE RESPONSE; DRUG USE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; SPAIN;

EID: 0029760719     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603001005     Document Type: Article

References (38)

1. De Abajo FJ, Serrano-Castro MA, Montero D, Rayón P, Madurga M, Palop R. Triazolam regulatory measures in Spain. Lancet 1993;341:185-6.
2. Consensus Conference. Drugs and insomnia: the use of medications to promote sleep. JAMA 1984;251:2410-4.
3. Russell J, Lader M. Guidelines for the prevention and treatment of henzodiazepine dependence. London: The Mental Health Foundation, 1993.
4. Drug Information Committee. Treatment of sleep disorders. Stockholm: National Board of Health and Welfare, 1988.
5. Anatomical therapeutic chemical (ATC) classification index including defined daily doses (DDDs) for plain substances. Oslo: WHO Collaborating Centre for Drugs Statistics Methodology, 1992:84.
6. Fitten LJ. Clinical assessment of insomnia in elderly persons. In: Albarede JL, Morley JE, Roth TV, Vellas BJ, eds. Sleep disorders and insomnia in the elderly. Facts and research in gerontology, Vol. 7. Paris: Serdi Publisher, 1993:127-46.
7. Nicholson AN. Hypnotics: their place in therapeutics. Drugs 1986;31: 164-76.
8. SAS Institute Inc. SAS/STAT user's guide. Release 6.03. Cary, NC: SAS Institute Inc., 1988.
9. SAS Institute Inc. SAS Technical Report P-200, SAS/STAT Software: CALIS and LOGISTIC Procedures, Release 6.04. Cary, NC: SAS Institute Inc., 1990.
10. Gené J, Soler M, Blay G, Holgado M, González RJ, Albero E. ¿Consumimos muchas benzodiazepinas? Med Clin (Barc) 1987;89:240-3.
11. Laporte JR, Capellá D, Gisbert R. The utilization of sedative-hypnotic drugs in Spain. In: Tognoni G, Bellantuono G, Lader M, eds. Epidemiological impact of psychotropic drugs. Amsterdam: Elsevier/North Holland, 1981:137-49.
12. Martín Arias LH, Carvajal A, Martín De Diego I, De Abajo F. Before and after triazolam: changes in the consumption of hypnotics in Spain. Br J Clin Pharmacol 1995;40:289-90.
13. Nordic Council on Medicines. Nordic Statistics on Medicines 1987-1989 (NLM Publication No 30). Uppsala, Sweden: Nordiska Läkemedelsnämnden, 1990.
14. Nordic Council on Medicines. Nordic Statistics on Medicines 1990-1992 (NLM Publication No 34). Uppsala, Sweden: Nordiska Läkemedelsnämnden, 1993.
15. Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Intern Med 1994;154:1235-40.
16. Mant A, McManus P. Benzodiazepine use - continuing to fall (letter). Med J Aust 1994;261:454.
17. Tiller JWG. Reducing the use of benzodiazepines in general practice. BMJ 1994;309:3-4.
18. Rickels K. Are benzodiazepines overused and abused? Br J Clin Pharmacol 1981;11(suppl):71S-83S.
19. Prinz PN, Vitiello MV. Sleep loss in aging. In: Albarede JL, Morley JE, Roth TV, Vellas BJ, eds. Sleep disorders and insomnia in the elderly. Facts and research in gerontology, Vol. 7. Paris: Serdi Publisher, 1993: 55-68.
20. Gabinete de Estudios Sociológicos Bernard Krief. Insomnio 2000. Estudio prospectivo Delphi. Libro blanco. Madrid: Rhône-Poulenc Rorer, SA, 1992.
21. Allen RM. Tranquilizers and sedative/hypnotics: appropriate use in the elderly. Geriatrics 1986;41:75-88.
22. Mellinger GD, Baiter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985;42:225-32.
23. Mant A, Duncan-Jones P, Saltman D, Bridges-Webb CH, Kehoe L, Lansbury G, et al. Development of long-term use of psychotropic drugs by general practice patients. Br Med J 1988;296:251-4.
24. Clift AD. Factors leading to dependence on hypnotic drugs. Br Med J 1972;3:614-7.
25. Nolan L, O'Malley K. Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol 1988;35:225-9.
26. Quera-Salva MA, Orluc A, Goldenberg F, Guilleminault C. Insomnia and use of hypnotics: study of a French population. Sleep 1991; 14:386-91.
27. Muller-Oerlinghausen B. Prescription and misuse of benzodiazepines in the Federal Republic of Germany. Pharmacopsychiatry 1986;19:8-13.
28. Khan A, Hornblow AR, Walshe JWB. Benzodiazepine dependence: a general practice survey. N Z Med J 1981;94:19-21.
29. Boethius G, Westerholm B. Is the use of hypnotics, sedatives and minor tranquilizers really a major health problem? Acta Med Scand 1976;199: 507-12.
30. Isacson D, Carsjö K, Bergman U, Blackburn JL. Long-term use of benzodiazepines in a Swedish community: an eight-year follow-up. J Clin Epidemiol 1992;45:429-36.
31. Isacson D, Bingefors K, Wennberg M, Dahlström M. Factors associated with high-quantity prescriptions of benzodiazepines in Sweden. Soc Sci Med 1993;36:343-51.
32. Balter MB, Manheimer DI, Mellinger GD, Uhlenhuth EH. A cross-national comparison of antianxiety/sedative drug use. Curr Med Res Opin 1984;8(suppl4):5-18.
33. Morgan K, Dallosso H, Ebrahim S, Arie T, Fentem PH. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. Br Med J 1988;296:601-2.
34. Bixler EO, Kales A, Soldatos CR, Kales JD, Healey S. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979;136:1257-62.
35. Williams P. Factors influencing the duration of treatment with psychotropic drugs in general practice: a survival analysis approach. Psychol Med 1983;13:623-33.
36. Mellinger GD, Baiter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984;251:375-9.
37. Lewis S. Doses of hypnotics. Lancet 1993;342:982.
38. Hartzema AG, Martini N. Pharmacoepidemiology: the role of the clinical pharmacist. Contemporary pharmacy issues. Kalamazoo, MI: The Upjohn Company, 1991.